Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1343-1355

  Norkute, Akvile ^a   Hieble, Andrea ^a   Braun, Alena ^a   Johann, Sonja ^a   Clarner, Tim ^a   Baumgartner, Werner ^b   Beyer, Cordian ^a   Kipp, Markus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cognitive impairment; Demyelination; Hippocampus; Multiple sclerosis

Indexed keywords

CUPRIZONE; LIPOPROTEIN; MYELIN BASIC PROTEIN; INDOLE DERIVATIVE; LUXOL FAST BLUE MBS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN REGION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; GRAY MATTER; HIPPOCAMPUS; HYPERPLASIA; HYPERTROPHY; IMMUNOCYTOCHEMISTRY; MACROGLIA; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE SECTION; WHITE MATTER; AGING; ANIMAL; ASTROCYTE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GLIOSIS; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; MYELIN SHEATH; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

AGING; ANIMALS; ASTROCYTES; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, ELECTRON; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65549106959     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21946     Document Type: Article

References (68)

1. Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C. 2008. 17β-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia (in press).
2. Aktas O, Schulze-Topphoff U, Zipp F. 2007. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 12:2912-2921.
3. Amato MP, Portaccio E, Zipoli V. 2006. Are there protective treatments for cognitive decline in MS? J Neurol Sci 245:183-186.
4. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
5. Binder MD, Cate HS, Prieto AL, Kemper D, Butzkueven H, Gresle MM, Cipriani T, Jokubaitis VG, Carmeliet P, Kilpatrick TJ. 2008. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 28:5195-5206.
6. Bird CM, Burgess N. 2008. The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 9:182-194.
7. Bobholz JA, Rao SM. 2003. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283-288.
8. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. 2002. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158-164.
9. Burns GA, Young MP. 2000. Analysis of the connectional organization of neural systems associated with the hippocampus in rats. Philos Trans R Soc Lond B Biol Sci 355:55-70.
10. Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P, Wood PM, Bunge MB, Whittemore SR. 2005. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25:6947-6957.
11. Cheung KK, Mok SC, Rezaie P, Chan WY. 2008. Dynamic expression of Dab2 in the mouse embryonic central nervous system. BMC Dev Biol 8:76.
12. DeLuca J, Gaudino EA, Diamond BJ, Christodoulou C, Engel RA. 1998. Acquisition and storage deficits in multiple sclerosis. J Clin Exp Neuropsychol 20:376-390.
13. DeLuca J, Chelune GJ, Tulsky DS, Lengenfelder J, Chiaravalloti ND. 2004. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? J Clin Exp Neuropsychol 26:550-562.
14. deToledo-Morrell L, Stoub TR, Wang C. 2007. Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease. Prog Brain Res 163:741-753.
15. Fontaine B, Seilhean D, Tourbah A, Daumas-Duport C, Duyckaerts C, Benoit N, Devaux B, Hauw JJ, Rancurel G, Lyon-Caen O. 1994. Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms. J Neurol Neurosurg Psychiatry 57:353-359.
16. Foong J, Rozewicz L, Davie CA, Thompson AJ, Miller DH, Ron MA. 1999. Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J Neuropsychiatry Clin Neurosci 11:45-50.
17. Franco-Pons N, Torrente M, Colomina MT, Vilella E. 2007. Behavioral deficits in the cuprizone-induced murine model of demyelination/ remyelination. Toxicol Lett 169:205-213.
18. Frotscher M. 1992. Application of the Golgi/electron microscopy technique for cell identification in immunocytochemical, retrograde labeling, and developmental studies of hippocampal neurons. Microsc Res Tech 23:306-323.
19. Frotscher M, Seress L, Schwerdtfeger WK, Buhl E. 1991. The mossy cells of the fascia dentata: a comparative study of their fine structure and synaptic connections in rodents and primates. J Comp Neurol 312:145-163
20. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P. 2007. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66:819-827.
21. Grivas I, Michaloudi H, Batzios C, Chiotelli M, Papatheodoropoulos C, Kostopoulos G, Papadopoulos GC. 2003. Vascular network of the rat hippocampus is not homogeneous along the septotemporal axis. Brain Res 971:245-249.
22. Hoffmann K, Lindner M, Groticke I, Stangel M, Loscher W. 2008. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice. Exp Neurol 210:308-321.
23. Horvat S, Beyer C, Arnold S. 2006. Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J Neurochem 99:937-951.
24. Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, Ting JP. 2008. TNF super-family member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. J Neuroimmunol 194:97-106.
25. Irvine KA, Blakemore WF. 2006. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 175:69-76.
26. Ivanova T, Beyer C. 2000. Ontogenetic expression and sex differences of aromatase and estrogen receptor-alpha/beta mRNA in the mouse hippocampus. Cell Tissue Res 300:231-237.
27. Ivanova T, Beyer C. 2001. Pre- and postnatal expression of brain-derived neurotrophic factor mRNA/protein and tyrosine protein kinase receptor B mRNA in the mouse hippocampus. Neurosci Lett 307:21-24.
28. Johann S, Kampmann E, Denecke B, Arnold S, Kipp M, Mey J, Beyer C. 2008. Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J Mol Neurosci 34:177-185.
29. Kajta M, Beyer C. 2003. Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 21:3-9.
30. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. 2005. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579-582.
31. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. 1999. Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17-26.
32. Kipp M, Karakaya S, Johann S, Kampmann E, Mey J, Beyer C. 2007. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J Neuroendocrinol 19:819-822.
33. Kipp M, Norkute A, Johann S, Lorenz L, Braun A, Hieble A, Gingele S, Pott F, Richter J, Beyer C. 2008. Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci 35:235-243.
34. Komoly S, Hudson LD, Webster HD, Bondy CA. 1992. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci U S A 89:1894-1898.
35. Kumaran D, Maguire EA. 2005. The human hippocampus: cognitive maps or relational memory? J Neurosci 25:7254-7259.
36. Lassmann H. 2008. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr Opin Neurol 21:242-247.
37. Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, Eikelenboom MI, Scheltens PH, Barkhof F, Polman CH. 2005. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 11:524-531.
38. Leranth C, Frotscher M. 1986. Synaptic connections of cholecystokinin-immunoreactive neurons and terminals in the rat fascia dentata: a combined light and electron microscopic study. J Comp Neurol 254:51-64.
39. Lovick TA, Brown LA, Key BJ. 1999. Neurovascular relationships in hippocampal slices: physiological and anatomical studies of mechanisms underlying flow-metabolism coupling in intraparenchymal microvessels. Neuroscience 92:47-60.
40. Lubbers K, Frotscher M. 1987. Fine structure and synaptic connections of identified neurons in the rat fascia dentata. Anat Embryol (Berl) 177:1-14.
41. Lycke J, Wikkelso C, Bergh AC, Jacobsson L, Andersen O. 1993. Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime. Eur Neurol 33:163-167.
42. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC. 2000. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 69:48-53.
43. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. 2000. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703-5708.
44. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046-7052.
45. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. 2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23:7710-7718.
46. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
47. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343:938-952.
48. Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodriguez-Antiguedad A, Matute C. 2008. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 195:194-198.
49. Pasquini LA, Calatayud CA, Bertone Una AL, Millet V, Pasquini JM, Soto EF. 2007. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279-292.
50. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129(Pt 12):3165-3172.
51. Pawlak J, Brito V, Kuppers E, Beyer C. 2005. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res 138:1-7.
52. Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA. 2007. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A 104:5638-5643.
53. Potter K. 2002. Magnetic resonance microscopy approaches to molecular imaging: sensitivity vs. specificity. J Cell Biochem Suppl 39:147-153.
54. Rao SM, Leo GJ, Bernardin L, Unverzagt F. 1991a. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685-691.
55. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. 1991b. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692-696.
56. Reisert I, Lieb K, Beyer C, Pilgrim C. 1996. Sex differentiation of rat hippocampal GABAergic neurons. Eur J Neurosci 8:1718-1724.
57. Rex S, Meyer PT, Baumert JH, Rossaint R, Fries M, Bull U, Schaefer WM. 2008. Positron emission tomography study of regional cerebral blood flow and flow-metabolism coupling during general anaesthesia with xenon in humans. Br J Anaesth 100:667-675.
58. Roman GC. 2004. Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res 26:454-458.
59. Rongve A, Aarsland D. 2006. Management of Parkinson's disease dementia: practical considerations. Drugs Aging 23:807-822.
60. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M. 2008. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172:1053-1061.
61. Stott SR, Kirik D. 2006. Targeted in utero delivery of a retroviral vector for gene transfer in the rodent brain. Eur J Neurosci 24:1897-1906.
62. Summers M, Fisniku L, Anderson V, Miller D, Cipolotti L, Ron M. 2008. Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 14:197-204.
63. Tekkok SB, Goldberg MP. 2001. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21:4237-4248.
64. Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N, Pelayo R, Comabella M, Sastre-Garriga J, Montalban X. 2006. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67:968-972.
65. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. 2005. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64:1101-1107.
66. Wells JE, Biernaskie J, Szymanska A, Larsen PH, Yong VW, Corbett D. 2005. Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice. Eur J Neurosci 21:187-196.
67. Williams A, Piaton G, Lubetzki C. 2007. Astrocytes - friends or foes in multiple sclerosis? Glia 55:1300-1312.
68. Zakzanis KK. 2000. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 15:115-136.